Lethal Ovarian Cancer Checked by Dual Attack on Immune Checkpoint, in Mice - Genetic Engineering & Biotechnology News

A study on mice showed a lethal ovarian cancer could be treated by two drugs that generate a significant antitumor immune response.

Hallmarks of a lethal form of ovarian cancer called “high-grade serous ovarian carcinoma” (HGSOC) are an immunosuppressive tumor microenvironment, insensitivity to checkpoint inhibitor immunotherapie… [+4974 chars]

full article...